TITLE

Individual Drugs

PUB. DATE
August 2003
SOURCE
WHO Drug Information;2003, Vol. 17 Issue 3, p156
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses issues concerning drug safety and efficacy. Role of statins in primary prevention; Management of noncommunicable diseases; Strategy to reduce cardiovascular disease.
ACCESSION #
11290944

 

Related Articles

  • Statins for all? A question for society. Barer, David // BMJ: British Medical Journal;7/12/2014, Vol. 349 Issue 7966, pg4192 

    A letter to the editor is presented which discusses clinical trials focusing on statin treatment for cardiovascular disease.

  • Using drugs to prevent CVD in high-risk patients. Alexander, Sidney; Weart, C. Wayne // Patient Care for the Nurse Practitioner;Oct2001, Vol. 4 Issue 10, p28 

    Provides information on pharmacologic regimens to prevent primary and secondary cardiac events in patients with high-risk for cardiovascular disease (CVD). Use of statins; Ways to lower lipid levels; Details of combination therapy for CVD. INSETS: Common misconceptions;Boosting medication...

  • Rosuvastatin significantly reduces the incidence of major cardiovascular events.  // Australian Journal of Pharmacy;May2009, Vol. 90 Issue 1068, p78 

    The article reports on the study that investigates the use of statins in primary prevention of cardiovascular event.

  • Statins provide no net benefit for low-risk patients.  // Reactions Weekly;11/2/2013, Issue 1476, p2 

    The article reports that according to the study "Should people at low risk of cardiovascular disease take a statin?," by J.D. Abramson statins are not much beneficial in the prevention of cardiovascular disease (CVD).

  • Statins for primary prevention of cardiovascular disease. Majeed, Azeem // BMJ: British Medical Journal;5/31/2014, Vol. 348 Issue 7960, p22 

    The author discusses the three key issues needed to be considered so as to fully implement a policy of extending statin treatment to a wider population. Topics covered include statistics on the use of statins in Great Britain, several factors that account for the high use of statins in the...

  • Bad medicine: statins. Spence, Des // BMJ: British Medical Journal;6/8/2013, Vol. 346 Issue 7911, p39 

    The article focuses on the effect of taking statins medicine by middle aged people suffering from vascular disease.

  • Doctor's orders. Newnham, David // Nursing Standard;3/5/2014, Vol. 28 Issue 27, p27 

    David Newnham wants to forget second opinions.

  • Analysis fuels debate on statins for low risk people. Kmietowicz, Zosia // BMJ: British Medical Journal;3/29/2014, Vol. 348 Issue 7951, p1 

    The article discusses how new findings that the risk of harmful effects from statins was very small is fueling a debate on whether statins should be extended to healthy people who are at low risk of cardiovascular disease. It cites the latest analysis of observational studies were researchers...

  • Looking at the Benefit of Statins from a Different Perspective. PHILLIPS, T. GRANT // American Family Physician;10/1/2010, Vol. 82 Issue 7, p741 

    A letter to the editor is presented in response to the article " Statins for Primary Prevention of Cardiovascular Disease (Tips from Other Journals)," by Crawford-Faucher in the December 15, 2009 issue.

  • Concerns about the latest NICE draft guidance on statins. McPherson, Klim // BMJ: British Medical Journal;7/12/2014, Vol. 349 Issue 7966, pg4130 

    A letter to the editor is presented which discusses the draft guidance issued by the British National Institute for Health and Care Excellence (NICE) regarding the clinical use of statins.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics